These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20443640)

  • 21. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.
    Yamazaki H; Shimada T
    Arch Biochem Biophys; 1997 Oct; 346(1):161-9. PubMed ID: 9328296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
    Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
    Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Terfenadine t-butyl hydroxylation catalyzed by human and marmoset cytochrome P450 3A and 4F enzymes in livers and small intestines.
    Uehara S; Yuki Y; Uno Y; Inoue T; Sasaki E; Yamazaki H
    Xenobiotica; 2018 Apr; 48(4):342-347. PubMed ID: 28436281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of 5-methylchrysene and 6-methylchrysene by human hepatic and pulmonary cytochrome P450 enzymes.
    Koehl W; Amin S; Staretz ME; Ueng YF; Yamazaki H; Tateishi T; Guengerich FP; Hecht SS
    Cancer Res; 1996 Jan; 56(2):316-24. PubMed ID: 8542586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
    Guengerich FP; Johnson WW
    Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Midazolam is metabolized by at least three different cytochrome P450 enzymes.
    Wandel C; Böcker R; Böhrer H; Browne A; Rügheimer E; Martin E
    Br J Anaesth; 1994 Nov; 73(5):658-61. PubMed ID: 7826796
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Uehara S; Murayama N; Higuchi Y; Shimizu M; Suemizu H; Guengerich FP; Yamazaki H
    Chem Res Toxicol; 2024 May; 37(5):671-674. PubMed ID: 38626399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
    Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
    J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progesterone hydroxylation by cytochromes P450 2C and 3A enzymes in marmoset liver microsomes.
    Nakanishi K; Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
    Xenobiotica; 2018 Aug; 48(8):757-763. PubMed ID: 28762864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo formation of dihydroxylated and glutathione conjugate metabolites derived from thalidomide and 5-Hydroxythalidomide in humanized TK-NOG mice.
    Yamazaki H; Suemizu H; Shimizu M; Igaya S; Shibata N; Nakamura M; Chowdhury G; Guengerich FP
    Chem Res Toxicol; 2012 Feb; 25(2):274-6. PubMed ID: 22268628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5.
    Lin HL; Kent UM; Hollenberg PF
    J Pharmacol Exp Ther; 2005 Apr; 313(1):154-64. PubMed ID: 15608076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics.
    Patten CJ; Thomas PE; Guy RL; Lee M; Gonzalez FJ; Guengerich FP; Yang CS
    Chem Res Toxicol; 1993; 6(4):511-8. PubMed ID: 8374050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regio- and Stereo-Selective Oxidation of a Cardiovascular Drug, Metoprolol, Mediated by Cytochrome P450 2D and 3A Enzymes in Marmoset Livers.
    Uehara S; Ishii S; Uno Y; Inoue T; Sasaki E; Yamazaki H
    Drug Metab Dispos; 2017 Aug; 45(8):896-899. PubMed ID: 28495902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo and in vitro diclofenac 5-hydroxylation mediated primarily by cytochrome P450 3A enzymes in common marmoset livers genotyped for P450 2C19 variants.
    Nakanishi K; Uehara S; Kusama T; Inoue T; Shimura K; Kamiya Y; Murayama N; Shimizu M; Uno Y; Sasaki E; Yamazaki H
    Biochem Pharmacol; 2018 Jun; 152():272-278. PubMed ID: 29626440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of cytochrome P450 3A5 in Escherichia coli: effects of 5' modification, purification, spectral characterization, reconstitution conditions, and catalytic activities.
    Gillam EM; Guo Z; Ueng YF; Yamazaki H; Cock I; Reilly PE; Hooper WD; Guengerich FP
    Arch Biochem Biophys; 1995 Mar; 317(2):374-84. PubMed ID: 7893152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen.
    Crewe HK; Notley LM; Wunsch RM; Lennard MS; Gillam EM
    Drug Metab Dispos; 2002 Aug; 30(8):869-74. PubMed ID: 12124303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High affinity of ergopeptides for cytochromes P450 3A. Importance of their peptide moiety for P450 recognition and hydroxylation of bromocriptine.
    Peyronneau MA; Delaforge M; Riviere R; Renaud JP; Mansuy D
    Eur J Biochem; 1994 Aug; 223(3):947-56. PubMed ID: 8055971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochromes P450 1A2 and 3A4 Catalyze the Metabolic Activation of Sunitinib.
    Amaya GM; Durandis R; Bourgeois DS; Perkins JA; Abouda AA; Wines KJ; Mohamud M; Starks SA; Daniels RN; Jackson KD
    Chem Res Toxicol; 2018 Jul; 31(7):570-584. PubMed ID: 29847931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH--cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates.
    Yamazaki H; Ueng YF; Shimada T; Guengerich FP
    Biochemistry; 1995 Jul; 34(26):8380-9. PubMed ID: 7599128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thalidomide metabolism by the CYP2C subfamily.
    Ando Y; Fuse E; Figg WD
    Clin Cancer Res; 2002 Jun; 8(6):1964-73. PubMed ID: 12060642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.